2014-06-05

Professor Charles Cantor joins InSilico Medicine, Inc. in the War on Aging as the Chair of the SAB



The Former Head of the Human Genome Project Joins InSilico Medicine, Inc. in the War on Aging as the Chair of the SAB

Dr. Cantor, one of the leaders of the Human Genome Project, has published more than 400 peer-reviewed articles, authored and co-authored more than 50 U.S. and international patents. He is also an author of the first genomics textbook, "Genomics: The Science and Technology of the Human Genome Project" and the three-volume textbook "Biophysical Chemistry". 

Charles Cantor, PhD, professor emeritus at Boston University and former principal scientist of the Human Genome Project joined the Science Advisory Board of InSilico Medicine, Inc.

"Aging is one of the most pressing problems facing the economies of the developed countries and there is an urgent need for new ways to increase productive longevity and screening the known drugs for their geroprotective properties and personalizing anti-cancer and aging-suppressive regiments using genetic and epigenetic analysis is one of the low hanging fruits in applied aging research. I am pleased to join the SAB of this international team dedicated to develop working solutions for both aging and age-related diseases", said Charles Cantor, PhD, chair of the Science Advisory Board of InSilico Medicine, Inc.
Dr. Cantor was the chairman of Genetics and Development at Columbia University College of Physicians & Surgeons, and Professor of Molecular Biology, University of California, Berkeley.

For more information please visit http://www.InSilicoMedicine.com .
Contact @ Insilico Medicine, Inc.:
InSilico Medicine, Inc.
Johns Hopkins University Eastern Campus
B301, 1101 East 33rd Street
Baltimore, MD 21218
Qinsong Zhu, PhD
Chief Operating Officer
+14107109674
zhu@insilicomedicine.com
This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/InSilico/Medicine/prweb11904553.htm



 

No comments:

Post a Comment